BRIEF-Cytokinetics Q4 Basic EPS USD -1.5

Reuters02-25
BRIEF-<a href="https://laohu8.com/S/CYTK">Cytokinetics</a> Q4 Basic EPS USD -1.5

Feb 24 (Reuters) - Cytokinetics Q4 R&D revenue USD 2.755 million.

  • Q4 net income USD -183.031 million
  • Q4 operating income USD -178.366 million
  • Q4 operating expenses USD 196.121 million

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment